Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 1 |
2019 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176.
Clin Infect Dis. 2021.
PMID: 32770240
Free PMC article.
Clinical Trial.
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.
Ivashchenko AA, Morozova MA, Vostokova NV, Beniashvily AG, Bukhanovskaya OA, Burminskiy DS, Egorova AN, Gluskina LY, Gorchakov DS, Karapetian RN, Kasimova LN, Kravchenko DV, Lepilkina TA, Merkulova EA, Mitkin OD, Penchul NA, Potanin SS, Rupchev GE, Ivachtchenko AV.
Ivashchenko AA, et al. Among authors: vostokova nv.
J Psychiatr Res. 2021 Nov;143:436-444. doi: 10.1016/j.jpsychires.2021.10.008. Epub 2021 Oct 11.
J Psychiatr Res. 2021.
PMID: 34656876
Clinical Trial.
Item in Clipboard
The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate.
Akulova E, Murashev B, Verevochkin S, Masharsky A, Al-Shekhadat R, Poddubnyy V, Zozulya O, Vostokova N, Kozlov AP.
Akulova E, et al. Among authors: vostokova n.
Vaccines (Basel). 2019 Aug 20;7(3):92. doi: 10.3390/vaccines7030092.
Vaccines (Basel). 2019.
PMID: 31434305
Free PMC article.
Item in Clipboard
Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025).
Ivachtchenko AV, Mitkin OD, Yamanushkin PM, Kuznetsova IV, Bulanova EA, Shevkun NA, Koryakova AG, Karapetian RN, Bichko VV, Trifelenkov AS, Kravchenko DV, Vostokova NV, Veselov MS, Chufarova NV, Ivanenkov YA.
Ivachtchenko AV, et al. Among authors: vostokova nv.
J Med Chem. 2014 Sep 25;57(18):7716-30. doi: 10.1021/jm500951r. Epub 2014 Sep 9.
J Med Chem. 2014.
PMID: 25148100
Item in Clipboard
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
Morozova M, Burminskiy D, Rupchev G, Lepilkina T, Potanin S, Beniashvili A, Lavrovsky Y, Vostokova N, Ivaschenko A.
Morozova M, et al. Among authors: vostokova n.
J Clin Psychopharmacol. 2017 Apr;37(2):169-175. doi: 10.1097/JCP.0000000000000673.
J Clin Psychopharmacol. 2017.
PMID: 28141622
Clinical Trial.
Item in Clipboard
Cite
Cite